These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fusion inhibitor approved. AIDS Patient Care STDS; 2003 May; 17(5):253. PubMed ID: 12816619 [No Abstract] [Full Text] [Related]
4. US FDA approves new class of HIV therapeutics. Robertson D Nat Biotechnol; 2003 May; 21(5):470-1. PubMed ID: 12721558 [No Abstract] [Full Text] [Related]
5. First fusion inhibitor for advanced HIV. Am J Nurs; 2003 Jul; 103(7):64F. PubMed ID: 12877130 [No Abstract] [Full Text] [Related]
6. Three new drugs approved by FDA. Hoyt G Surviv News (Atlanta Ga); 2003; ():13, 20. PubMed ID: 14696579 [No Abstract] [Full Text] [Related]
7. [FDA approved the first of a new class of antiretrovirals for adults and children with advanced HIV infection]. Rev Panam Salud Publica; 2003 Jul; 14(1):57-8. PubMed ID: 12952609 [No Abstract] [Full Text] [Related]
8. [Strategies for combating resistances in HIV therapy--an exemplifying case]. Stoehr A MMW Fortschr Med; 2004 Apr; 146 Spec No 1():70-1. PubMed ID: 15373056 [No Abstract] [Full Text] [Related]
9. Long path to approval. A look back at the road to Fuzeon. GMHC Treat Issues; 2003 Mar; 17(3):1-5. PubMed ID: 12728856 [No Abstract] [Full Text] [Related]
10. New-Fill on "hold" and open-label for T-20. Berger DS Posit Aware; 2002; 13(1):64-5. PubMed ID: 12216532 [No Abstract] [Full Text] [Related]
11. [Fusion inhibitors. One year therapy with T-20--initial evaluation]. Goebel FD MMW Fortschr Med; 2004 Apr; 146 Spec No 1():42-3. PubMed ID: 15373046 [No Abstract] [Full Text] [Related]
12. Fresh data on new anti-HIV drugs presented in Durban. Leibovich M Posit Living; 2000 Aug; 9(7):16-7. PubMed ID: 12492026 [No Abstract] [Full Text] [Related]
13. T-20 being called "miraculous". AIDS Patient Care STDS; 2002 Sep; 16(9):462. PubMed ID: 12412581 [No Abstract] [Full Text] [Related]